Approach to the Athlete with Sickle Cell Trait

To begin the course, please login or register by clicking ENROLL. After logging in, you will be able to complete the pretest and view the video/documents. You will have the option to complete the posttest, evaluation and receive credit. Some courses may have an associated cost.

Step Status
Video/Document(s)
Posttest
Evaluation
Starts On: 7/1/2019: 12:00 AM
Ends On: 6/30/2020: 12:00 AM
Session Type: Internet Activity Enduring Material
Credits: 0.75
Description:

Faculty

Morey A. Blinder, MD
Professor, Medicine
Division of Hematology
Associate Professor, Pathology and Immunology
Financial Relationships
Research Support/Grants: Ablynx, Global Blood Therapeutics Inc., Incyte Corporation, Bioverativ Therapeutics Inc., and Missouri Foundation for Health/MFH
Speakers Bureau/Honoraria: Amgen Inc., CSL Behring, Janssen Pharmaceuticals Inc., Novartis Pharma AG, and Portola Pharmaceuticals Inc.
Consulting/Advisory Committees: Novartis Pharma AG and Portola Pharmaceuticals Inc.

Presenters should indicate if speaking off label. This activity originated as a presentation at the CME activity, 12th Annual Sports Medicine Update, March 29, 2019, which was supported in part by The St. Louis Children's Hospital Foundation and Young Athlete Center: Taylor Edelen Fund

Planning Committee

Kim M. Cordia, RN, BSN, MS, ONC
Pediatric Nurse Manager Children's Specialty Care Center
Financial Relationships: Nothing to disclose

Mark E. Halstead, MD
Associate Professor of Orthopedic Surgery
Departments of Pediatrics and Orthopedics
Director, Sports Concussion Program
Medical Director, Young Athlete Center
Medical Director, Progress West Clinic
Financial Relationships Nothing to disclose

Objectives: The intended result of this activity is increased knowledge/competence, and upon completion of this course, participants should be able to:
  • Discuss the diagnosis process and screening for sickle cell trait.
  • Differentiate between exertional collapse associated with sickle trait (ECAST) from other acute medical illnesses in the athlete.
  • Identify the approach to prevention and treatment of ECAST
Additional Information:
Target Audience: This course is designed for pediatricians, primary care/family practice, sports medicine professionals, physical medicine & rehabilitation physicians, internists, orthopedic surgeons, neurologists, emergency medicine, psychologists, psychiatrists, chiropractors, nurse practitioners, physician assistants, physical therapists and athletic trainers.

Publication Date: July 1, 2019
Expiration Date: June 30, 2020

Accreditation Information:
wustlcme
In support of improving patient care, Washington University School of Medicine in St. Louis is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Credit Awarded for this Activity:
Credit Statement: American Medical Association (AMA Credit)
Washington University School of Medicine in St. Louis designates this enduring material for a maximum of .75 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
American Nurses Credentialing Center (ANCC Credit)
Washington University School of Medicine in St. Louis designates this enduring material for a maximum of .75 ANCC contact hour.

References:
  • Boden BP et al. Am J Sports Med 2013; 41:1108
  • NCAA Student-Athlete Ethnicity Report http://www.ncaapublications.com/productdownloads/SAEREP11.pdf
  • Martin TW et al. Am J Med 1989;87:48
  • Eichner ER. Clin Sports Med 2011;30:537-549
  • Osnes J and Hermansen J Applied Physiol 1972;32:59
  • Lange RD, Minnich V Moore CV J Lab Clin Med 1951;37:789
Disclosure Information: It is the policy of Washington University School of Medicine in St. Louis, Continuing Medical Education, to ensure balance, independence, objectivity and scientific rigor in all its educational activities. All planners, faculty and other persons who may influence content of this CME activity have disclosed all relevant financial relationships with commercial interests. All disclosures have been reported and are indicated with their presentations. Any potential conflicts were addressed and resolved.

Presenters are also expected to openly disclose inclusion of discussion of any off-label, experimental, or investigational use of drugs or devices in their presentations.

Presentations are expected to be based on evidence that is accepted within the profession of medicine as adequate justification for their indication in the care of patients. All scientific research should conform to the generally accepted standards of experimental design, data collection and analysis. These presentations are not an endorsement of any commercial interests.

These presentations are the views and experiences of the presenters. The presenters' views do not represent the policy or position of Washington University School of Medicine in St. Louis. Washington University School of Medicine in St. Louis, Continuing Medical Education, is the provider for CME credits.
Categories: Hematology, Nurse, Orthopedic


Powered By AI 4.5